Who Exports Vinorelbine from India — 78 Suppliers Behind a $3.4M Market
India's vinorelbine export market is supplied by 78 active exporters who collectively shipped $3.4M across 439 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 37.1% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and FRESENIUS KABI ONCOLOGY LIMITED. The top 5 suppliers together control 81.4% of total export value, reflecting a concentrated market structure.
Top Vinorelbine Exporters from India — Ranked by Export Value
INTAS PHARMACEUTICALS LIMITED is the leading vinorelbine exporter from India, holding a 37.1% share of the $3.4M market across 439 shipments from 78 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, UNITED BIOTECH PRIVATE LIMITED, NV REMEDIES PRIVATE LIMITED — collectively control 81.4% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (37.1%), EUGIA PHARMA SPECIALITIES LIMITED (22.9%), FRESENIUS KABI ONCOLOGY LIMITED (15.1%), UNITED BIOTECH PRIVATE LIMITED (3.2%), NV REMEDIES PRIVATE LIMITED (3.0%).
Top Vinorelbine Exporters from India
Ranked by export value · 78 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED PHARMA DRUGS & MEDI VINORELBINE INJ,10MGPHARMA DRUGS & MEDI:VINORELBINE INJ,10MGPHARMA DRUG&MED:VINORELBINE INJ,10MG/ML, | $1.3M | 6 | 37.1% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED VINORELBINE TARTRATE 10 MG/ML FOR INFUSI | $776.6K | 1 | 22.9% |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED VINELBINE USP INJ. 50MG/5MVINELBINE USP INJ. 50MG/5ML VIALVINELBINE USP INJECTION 50 | $512.3K | 8 | 15.1% |
| 4 | UNITED BIOTECH PRIVATE LIMITED VINOTEC 50 , B/N:VNIC5B2,MD:03/2025,ED:02/2027 | $110.1K | 4 | 3.2% |
| 5 | NV REMEDIES PRIVATE LIMITED VINORELBINE-MILI 50MG/5ML VINORELBINE SO | $101.6K | 1 | 3.0% |
| 6 | VENUS REMEDIES LIMITED VINORELBINE SOLUTION FOR INJECTION (50MGVINORELBINE SOLUTION FOR INJECTION (10MG | $89.7K | 1 | 2.6% |
| 7 | S HIMATLAL HEALTHCARE LLP PHARMA DRUGS & MEDI VINORELBINE INJ,10MGVINELBINE USP INJ. 50MG/5MVINORELBINE TARTRATE 10 MG/ML FOR INFUSI | $23.5K | 3 | 0.7% |
| 8 | S. HIMATLAL HEALTHCARE LLP | $16.1K | 1 | 0.5% |
| 9 | 3S CORPORATION VINELBINE USP INJ. 50MG/5MVINELBINE USP INJ. 50MG/5ML VIALVINELBINE VINORELBINE USP INJ. 50MG/5M | $14.4K | 4 | 0.4% |
| 10 | VEA IMPEX I PRIVATE LIMITED | $12.6K | 3 | 0.4% |
| 11 | J.A. UNITED EXPORTS PRIVATE LIMITED | $12.6K | 2 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Vinorelbine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Intas Pharmaceuticals Limited | Warning Letter, November | Yes | Yes | Not verified | Received FDA Warning Letter for CGMP violations; WHO-GMP and EU GMP certified. |
| Eugia Pharma Specialities Limited | Warning Letter, August 20 | Unknown | Unknown | Not verified | Received FDA Warning Letter for CGMP violations; WHO-GMP and EU GMP status not f |
| United Biotech Private Limited | Not Listed | Yes | Unknown | Not verified | WHO-GMP certified; no FDA listing or warning letters found. |
| Venus Remedies Limited | Not Listed | Yes | Unknown | Not verified | WHO-GMP certified; no FDA listing or warning letters found. |
| Fresenius Kabi Oncology Limited | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
| NV Remedies Private Limited | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
| S. Himatlal Healthcare LLP | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
| 3S Corporation | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
| VEA Impex I Private Limited | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
| J.A. United Exports Private Limited | Not Listed | Unknown | Unknown | Not verified | No FDA listing or warning letters found; WHO-GMP and EU GMP status not found. |
TransData Nexus reviewed the regulatory standing of 10 leading Vinorelbine exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 1 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Vinorelbine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This concentration of expertise and infrastructure makes Hyderabad a critical center for the initial stages of drug development and manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies such as Intas Pharmaceuticals and Torrent Pharmaceuticals are headquartered here, emphasizing the region's strength in producing finished dosage forms. This specialization ensures a robust supply chain for the formulation and packaging of drugs like Vinorelbine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region in Maharashtra serves as a vital export gateway for pharmaceuticals. With its proximity to major ports and a well-established logistics network, this cluster facilitates the efficient export of pharmaceutical products to international markets. Companies like Sun Pharmaceutical Industries, headquartered in Mumbai, leverage this strategic location to distribute their products globally.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, largely due to favorable tax incentives and supportive government policies. This area attracts numerous pharmaceutical companies, contributing to the production capacity and diversification of India's pharmaceutical industry.
5Sourcing Recommendations
- Diversify Supplier Base: While major suppliers like Intas Pharmaceuticals and EUGIA Pharma Specialities dominate Vinorelbine exports, consider engaging with emerging manufacturers in regions like Baddi-Nalagarh to mitigate supply chain risks.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad cluster to streamline export processes and reduce lead times for international shipments.
- Monitor Regulatory Compliance: Ensure that suppliers across different clusters adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
- Assess Cost-Benefit of Tax Incentives: Evaluate the financial advantages offered by manufacturing in tax incentive zones like Baddi-Nalagarh against potential logistical challenges to optimize overall supply chain efficiency.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Vinorelbine exporters from India
INTAS PHARMACEUTICALS LIMITED — Intas Acquires UDENYCA® Business from Coherus BioSciences
Intas Pharmaceuticals, through its U.S. specialty division Accord BioPharma, announced an agreement to acquire the UDENYCA® (pegfilgrastim-cbqv) business from Coherus BioSciences. UDENYCA® is a biosimilar to Neulasta®, used to decrease infection incidence in chemotherapy patients. - IMPACT: This acquisition enhances Intas's biosimilar portfolio, potentially increasing its market share and resources for Vinorelbine production and export.
Impact: This acquisition enhances Intas's biosimilar portfolio, potentially increasing its market share and resources for Vinorelbine production and export.
Common Questions — Vinorelbine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which vinorelbine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 164 recorded shipments worth $1.3M. EUGIA PHARMA SPECIALITIES LIMITED (24 shipments) and FRESENIUS KABI ONCOLOGY LIMITED (27 shipments) are also established high-volume exporters.
Q How many vinorelbine manufacturers are there in India?
India has 78 active vinorelbine exporters with a combined export market of $3.4M across 439 shipments to 60 countries. The top 5 suppliers hold 81.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for vinorelbine from India?
Average FOB unit price: $21.45 per unit, ranging from $0.50 to $310.91. Average shipment value: $7.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 78 verified Indian exporters of Vinorelbine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 439 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 60 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
439 Verified Shipments
78 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists